Financial News

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Transdigm Group Incorporated Common Stock (NY:TDG)

1,377.20 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, Mar 28, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Transdigm Group Incorporated Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
2 Reasons ROCK is Risky and 1 Stock to Buy Instead
Although the S&P 500 is down 1.4% over the past six months, Gibraltar’s stock price has fallen further to $62.15, losing shareholders 11.1% of their capital. This may have investors wondering how to... 
Via StockStory
Topics Economy Government Stocks
Exposures Interest Rates Political Supply Chain
3 Reasons LSTR is Risky and 1 Stock to Buy Instead
Over the past six months, Landstar’s stock price fell to $151.87. Shareholders have lost 18.8% of their capital, disappointing when considering the S&P 500 was flat. This was partly due to its softer... 
Via StockStory
Topics Stocks
Exposures US Equities
3 Reasons to Sell SWK and 1 Stock to Buy Instead
Shareholders of Stanley Black & Decker would probably like to forget the past six months even happened. The stock dropped 28.7% and now trades at $78.23. This may have investors wondering how to... 
Via StockStory
3 Reasons to Sell NVEE and 1 Stock to Buy Instead
Over the last six months, NV5 Global’s shares have sunk to $18.92, producing a disappointing 18.9% loss while the S&P 500 was flat. This may have investors wondering how to approach the situation. 
Via StockStory
Topics Stocks
Exposures US Equities
3 Reasons to Sell CORT and 1 Stock to Buy Instead
Corcept currently trades at $58.76 and has been a dream stock for shareholders. It’s returned 434% since March 2020, blowing past the S&P 500’s 117% gain. The company has also beaten the index over the... 
Via StockStory
Topics Stocks
Exposures US Equities
3 Reasons AME is Risky and 1 Stock to Buy Instead
AMETEK currently trades at $177.60 per share and has shown little upside over the past six months, posting a middling return of 3.7%. 
Via StockStory
3 Reasons to Sell FAST and 1 Stock to Buy Instead
Over the past six months, Fastenal has been a great trade. While the S&P 500 was flat, the stock price has climbed by 9.1% to $77.12 per share. This run-up might have investors contemplating their next... 
Via StockStory
Topics Stocks
Exposures US Equities
3 Reasons IEX is Risky and 1 Stock to Buy Instead
Over the past six months, IDEX’s shares (currently trading at $184.50) have posted a disappointing 13.2% loss while the S&P 500 was flat. This was partly due to its softer quarterly results and may... 
Via StockStory
Topics Stocks
Exposures US Equities
EVgo (EVGO): Buy, Sell, or Hold Post Q4 Earnings?
EVgo’s stock price has taken a beating over the past six months, shedding 32.2% of its value and falling to $2.80 per share. This might have investors contemplating their next move. 
Via StockStory
Topics Electric Vehicles
Exposures Electric Vehicles
3 Reasons to Avoid DOV and 1 Stock to Buy Instead
Dover currently trades at $181.55 per share and has shown little upside over the past six months, posting a small loss of 5%. 
Via StockStory
3 Reasons to Avoid AL and 1 Stock to Buy Instead
Air Lease currently trades at $47 per share and has shown little upside over the past six months, posting a middling return of 3.9%. However, the stock is beating the S&P 500’s 1.4% decline during that... 
Via StockStory
Topics Stocks
Exposures US Equities
Hanesbrands (HBI): Buy, Sell, or Hold Post Q4 Earnings?
Over the past six months, Hanesbrands’s shares (currently trading at $6.03) have posted a disappointing 10% loss while the S&P 500 was down 1.4%. This was partly driven by its softer quarterly results... 
Via StockStory
Topics Stocks
Exposures US Equities
Akamai (AKAM): Buy, Sell, or Hold Post Q4 Earnings?
Although the S&P 500 is down 1.4% over the past six months, Akamai’s stock price has fallen further to $81.54, losing shareholders 19% of their capital. This was partly due to its softer quarterly... 
Via StockStory
Topics Stocks
Exposures US Equities
3 Reasons DM is Risky and 1 Stock to Buy Instead
What a brutal six months it’s been for Desktop Metal. The stock has dropped 46.3% and now trades at $2.42, rattling many shareholders. This was partly due to its softer quarterly results and may have... 
Via StockStory
Boyd Gaming (BYD): Buy, Sell, or Hold Post Q4 Earnings?
Boyd Gaming currently trades at $69.26 and has been a dream stock for shareholders. It’s returned 497% since March 2020, more than tripling the S&P 500’s 149% gain. The company has also beaten the... 
Via StockStory
Topics Stocks
Exposures US Equities
Wyndham (WH): Buy, Sell, or Hold Post Q4 Earnings?
Since March 2020, the S&P 500 has delivered a total return of 149%. But one standout stock has nearly doubled the market - over the past five years, Wyndham has surged 261% to $92.17 per share. Its... 
Via StockStory
Topics Stocks
Exposures US Equities
Q4 Earnings Highlights: TransDigm (NYSE:TDG) Vs The Rest Of The Aerospace Stocks
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how TransDigm (NYSE:TDG) and the... 
Via StockStory
Topics Emissions
Redfin (RDFN): Buy, Sell, or Hold Post Q4 Earnings?
Over the past six months, Redfin’s shares (currently trading at $11.05) have posted a disappointing 16.6% loss while the S&P 500 was down 1.6%. This may have investors wondering how to approach the... 
Via StockStory
Topics Stocks
Exposures US Equities
Masco (MAS): Buy, Sell, or Hold Post Q4 Earnings?
Over the past six months, Masco’s shares (currently trading at $70.99) have posted a disappointing 14.7% loss while the S&P 500 was down 1.7%. This might have investors contemplating their next move. 
Via StockStory
Topics Stocks
Exposures US Equities
Solventum (SOLV): Buy, Sell, or Hold Post Q4 Earnings?
Solventum has been treading water for the past six months, recording a small return of 2.6% while holding steady at $74.01. 
Via StockStory
Sinclair (SBGI): Buy, Sell, or Hold Post Q4 Earnings?
Over the past six months, Sinclair has been a great trade. While the S&P 500 was flat, the stock price has climbed by 10.5% to $15.55 per share. This was partly thanks to its solid quarterly results,... 
Via StockStory
Topics Stocks
Exposures US Equities
3 Reasons CSCO is Risky and 1 Stock to Buy Instead
Over the past six months, Cisco has been a great trade. While the S&P 500 was flat, the stock price has climbed by 20.2% to $60.80 per share. This was partly thanks to its solid quarterly results, and... 
Via StockStory
Topics Stocks
Exposures US Equities
Itron (ITRI): Buy, Sell, or Hold Post Q4 Earnings?
Itron has been treading water for the past six months, recording a small loss of 0.7% while holding steady at $103.61. 
Via StockStory
3 Reasons to Sell RGR and 1 Stock to Buy Instead
Ruger has been treading water for the past six months, recording a small loss of 3.7% while holding steady at $39.90. 
Via StockStory
Topics Firearms
Exposures Firearms
2 Reasons to Avoid DPZ and 1 Stock to Buy Instead
Domino's currently trades at $427.48 per share and has shown little upside over the past six months, posting a middling return of 4.5%. However, the stock is beating the S&P 500’s 1.2% decline during... 
Via StockStory
Topics Stocks
Exposures US Equities
3 Reasons to Sell TMO and 1 Stock to Buy Instead
Over the last six months, Thermo Fisher shares have sunk to $508.90, producing a disappointing 17.1% loss - worse than the S&P 500’s 1.2% drop. This might have investors contemplating their next move. 
Via StockStory
Topics Stocks
Exposures US Equities
3 Reasons to Sell ELAN and 1 Stock to Buy Instead
Elanco has gotten torched over the last six months - since September 2024, its stock price has dropped 28.5% to $10.39 per share. This was partly due to its softer quarterly results and might have... 
Via StockStory
What Does the Market Think About TransDigm Gr?
Via Benzinga
The Nasdaq Just Hit Correction Territory: 2 Pullback Stocks to Buy and Hold for a Decade
Via The Motley Fool
3 Reasons MRNA is Risky and 1 Stock to Buy Instead
Moderna has gotten torched over the last six months - since September 2024, its stock price has dropped 51.2% to $33.99 per share. This was partly due to its softer quarterly results and might have... 
Via StockStory
Exposures COVID-19
< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback